Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 8,880 shares at $254.14 ($2.3M) on 2022-08-11, disclosed to the SEC on 2022-08-12.
Open-market sale of $2.3M RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $254.14 | 4,040 | $1.0M | 45.5% |
| 2 | $254.14 | 4,040 | $1.0M | 45.5% |
| 3 | $255.20 | 800 | $204K | 9.0% |
| Total | $254.24 avg | 8,880 | $2.3M | 100% |
| Filing → |
| RGEN | SELL | 2024-03-12 | $1.4M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-06-14 | $2.6M | — | Filing → |